
Aspen RxHealth: App-based pharmacy service providing personalized care anytime, anywhere.
Aspen RxHealth was founded with the mission to revolutionize pharmacy practice by leveraging technology to connect patients with pharmacists anytime, anywhere. Their app-based platform offers a range of services including medication therapy management, condition management, medication adherence, and transitions of care. Aspen RxHealth aims to provide personalized care through a community of pharmacists, enhancing patient outcomes and reducing healthcare costs. Their market focus includes health plans, life sciences, and provider groups.
Notable affiliated individuals include experienced pharmacists and healthcare professionals who contribute to the platform's robust service offerings. Aspen RxHealth has attracted significant investment from venture capital firms focused on healthcare innovation. Key achievements include successful partnerships with major health plans and positive patient outcomes reported through their services. The overall impact of Aspen RxHealth is seen in its ability to improve medication adherence and patient education, ultimately contributing to better health management and reduced hospital readmissions.

RxLive
rxlive.com

Health Haven Rx
healthhavenrx.com

PipelineRx
pipelinerx.com

SmithRx
smithrx.com

RxAnte
rxante.com

House Rx
houserx.com

RobinHealth

Scene Health
scene.health

ActualMeds
actualmeds.com

NimbleRx
nimblerx.com

iMedicare
imedicare.com

ScriptAssist Pharmacy
scriptassistrx.com

NuScriptRx
nuscriptrx.com

Aprexis Health Solutions
aprexis.com

GeniusRx
geniusrx.com
Companies similar to Aspen RxHealth include RxLive, Health Haven Rx, PipelineRx and SmithRx.
Aspen RxHealth was founded in 2018.
Aspen RxHealth's headquarters is located in Tampa, FL, US.
Aspen RxHealth's most recent funding round was for $23M (USD) in January 2021.
As of Jan 7, 2021, Aspen RxHealth has disclosed funding of $35M (USD). Undisclosed round amounts are excluded.
Aspen RxHealth has 657 employees as of Feb 4, 2024.